Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions

CompletedOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

March 15, 2017

Primary Completion Date

September 16, 2019

Study Completion Date

September 16, 2019

Conditions
Arthritis, Rheumatoid
Trial Locations (13)

15086

Clínica San Judas Tadeo, Lima

111211

Clinicos IPS, Bogotá

Unknown

Artmedica, Medellín

Fundacion Instituto de Reumatologia Fernando Chalem, Bogota

IDEARG, Bogota

Clinica de Occidente, Santiago de Cali

Centro Integral de Reumatología del Caribe Circaribe S.A, Barranquilla

Centro de Investigacion en Reumatologia y Especialidades Medicas S.A.S, CIREEM, Bogotá

SERVIMED, Bucaramanga

REUMALAB, Medellín

Fundacion Valle del Lili, Santiago de Cali

Centro Medico CEEN, Arequipa

Clinica Jockey Salud, Lima

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY